Mrs. Rosalie Baker Lambeth, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 503 N 21st St, Camphill, PA 17011 Phone: 717-763-2121 |
News Archive
The National Patient Advocate Foundation - the sister organization to the Patient Advocate Foundation - a direct patient services organization that assists patients throughout the country – delivered a message to all White House Summit participants that policy agreement must triumph over partisan politics during the bipartisan health care reform meeting.
Kaiser Health News' Blog Watch column details some of yesterday's chatter in the blogosphere. "It was a long day of commentary for many health policy bloggers, who concluded that President Barack Obama signaled his intention to push forward with the current proposals, though who will score the most political points from the seven hour health care summit remains contentious"
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
Gilead Sciences, Inc. today announced topline results from a Phase 3 clinical trial (Study GS-US-334-0118) in Japan evaluating the once-daily nucleotide analog polymerase inhibitor sofosbuvir in combination with ribavirin (RBV) for the treatment of genotype 2 chronic hepatitis C virus (HCV) infection.
› Verified 3 days ago